Recent advances in mRNA technology for cancer vaccines show promise with improved stability, targeted delivery, and AI-driven antigen design, transforming immunotherapy approaches. Cutting-edge mRNA v...
A study using mRNA technology to produce thymic proteins in the liver boosts T-cell production in aged mice, highlighting potential for aging-related immune decline treatments. Researchers have develo...
New cancer treatments, including mRNA vaccines and targeted therapies, are reducing recurrence risks and improving survival rates, with innovations making care more equitable and effective. Innovative...
